Emma Bragantini

1.0k total citations
29 papers, 399 citations indexed

About

Emma Bragantini is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Emma Bragantini has authored 29 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 11 papers in Reproductive Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Emma Bragantini's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Genetic factors in colorectal cancer (5 papers). Emma Bragantini is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Genetic factors in colorectal cancer (5 papers). Emma Bragantini collaborates with scholars based in Italy, United States and Poland. Emma Bragantini's co-authors include Mattia Barbareschi, Paolo Palma, Chiara Cantaloni, Gian Franco Zannoni, Silvia Fasanella, Elena Leonardi, Claudio Eccher, Antonella Ferro, D Aldovini and Luca Morelli and has published in prestigious journals such as International Journal of Molecular Sciences, The American Journal of Surgical Pathology and Gynecologic Oncology.

In The Last Decade

Emma Bragantini

29 papers receiving 390 citations

Peers

Emma Bragantini

ONCOL

PRM

Mijke Bol Netherlands

Amy Joehlin‐Price United States

Seyran Yiğit Türkiye

Elizabeth Kornaga Canada

Lorenzo Ferrando Italy

Asaf Maoz United States

Yeqian Feng China

Harish Kumar United Kingdom

S A Bartow United States

Mijke Bol Netherlands

Emma Bragantini

118 ×0.8

89 ×0.6

137 ×1.1

ONCOL

171 ×1.8

PRM

41 ×0.5

Citations per year, relative to Emma Bragantini Emma Bragantini (= 1×) peers Mijke Bol

Countries citing papers authored by Emma Bragantini

Since Specialization

Citations

This map shows the geographic impact of Emma Bragantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Bragantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Bragantini more than expected).

Fields of papers citing papers by Emma Bragantini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Bragantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Bragantini. The network helps show where Emma Bragantini may publish in the future.

Co-authorship network of co-authors of Emma Bragantini

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Bragantini. A scholar is included among the top collaborators of Emma Bragantini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Bragantini. Emma Bragantini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zannoni, Gian Franco, Giuseppe Angelico, Saveria Spadola, et al.. (2025). Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC). Gynecologic Oncology. 194. 1–10. 1 indexed citations

Macciò, Livia, Antonio Travaglino, Emma Bragantini, et al.. (2025). Immunophenotype of uterine tumor resembling ovarian sex cord tumor (UTROSCT): Case series and meta-analysis of the literature. Pathology - Research and Practice. 266. 155822–155822. 1 indexed citations

Macciò, Livia, Damiano Arciuolo, Angela Santoro, et al.. (2025). Clinicopathological Comparison Between GREB1- and ESR1-Rearranged Uterine Tumors Resembling Ovarian Sex Cord Tumors (UTROSCTs): A Systematic Review. Diagnostics. 15(6). 792–792. 2 indexed citations

Santoro, Angela, Giuseppe Angelico, Antonio Travaglino, et al.. (2024). Beyond the WHO 2020 Classification of Female Genital Tumors: Types of Endometrial Cancer: A Pathological and Molecular Focus on Challenging Rare Variants. International Journal of Molecular Sciences. 25(19). 10320–10320. 1 indexed citations

Santoro, Angela, Giuseppe Angelico, Antonio Travaglino, et al.. (2024). The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features. Critical Reviews in Oncology/Hematology. 208. 104603–104603. 2 indexed citations

Santoro, Angela, Frediano Inzani, Giuseppe Angelico, et al.. (2023). Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors. Cancers. 15(4). 1137–1137. 23 indexed citations

Bragantini, Emma, et al.. (2023). Gastric (gastrointestinal)-type endometrial adenocarcinoma presenting as a solitary endometrial polyp: a case report and literature review on a novel and potentially aggressive endometrial cancer histotype. Pathologica. 115(4). 227–231. 2 indexed citations

Viel, Giovanni, Francesco Antonio Ciarleglio, Stefano Marcucci, et al.. (2023). Appendiceal collision tumors: case reports, management and literature review. Frontiers in Surgery. 10. 1184322–1184322. 1 indexed citations

Chapel, David B., Aarti Sharma, Livia Macciò, et al.. (2022). Fumarate Hydratase and S-(2-Succinyl)-Cysteine Immunohistochemistry Shows Evidence of Fumarate Hydratase Deficiency in 2% of Uterine Leiomyosarcomas: A Cohort Study of 348 Tumors. International Journal of Gynecological Pathology. 42(2). 120–135. 9 indexed citations

10.

Zannoni, Gian Franco, Angela Santoro, Nicoletta D’Alessandris, et al.. (2022). Biomarker characterization in endometrial cancer in Italy: first survey data analysis. Pathologica. 114(3). 189–198. 9 indexed citations

11.

Zannoni, Gian Franco, Emma Bragantini, Francesca Castiglione, et al.. (2022). Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group. Frontiers in Oncology. 12. 805613–805613. 15 indexed citations

12.

Chapel, David B., Aarti Sharma, Ricardo R. Lastra, et al.. (2022). A novel morphology-based risk stratification model for stage I uterine leiomyosarcoma: an analysis of 203 cases. Modern Pathology. 35(6). 794–807. 11 indexed citations

13.

Feraco, Paola, et al.. (2020). Oropharyngeal Hairy Polyp: A Case of Respiratory Failure in a Newborn. Diagnostics. 10(7). 465–465. 3 indexed citations

14.

Fasanella, Silvia, Elena Leonardi, Chiara Cantaloni, et al.. (2011). Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies. Diagnostic Pathology. 6(S1). S7–S7. 84 indexed citations

15.

Cantaloni, Chiara, Claudio Eccher, Luca Morelli, et al.. (2011). Diagnostic Value of Automated Her2 Evaluation in Breast Cancer. Applied immunohistochemistry & molecular morphology. 19(4). 306–312. 15 indexed citations

16.

Vescovo, Valerio Del, Chiara Cantaloni, Alberto Cucino, et al.. (2011). miR-205 Expression Levels in Nonsmall Cell Lung CancerDo Not Always Distinguish Adenocarcinomas From Squamous Cell Carcinomas. The American Journal of Surgical Pathology. 35(2). 268–275. 45 indexed citations

17.

D’Arca, Domenico, Fedra Gottardo, Emma Bragantini, et al.. (2009). Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor. Urologic Oncology Seminars and Original Investigations. 28(2). 189–194. 13 indexed citations

18.

Cossu‐Rocca, Paolo, Matteo Brunelli, Stefano Gobbo, et al.. (2007). Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Modern Pathology. 20(7). 722–728. 56 indexed citations

19.

Bragantini, Emma, Stefano Barbi, Stefania Beghelli, et al.. (2005). Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker. Journal of Cancer Research and Clinical Oncology. 132(1). 45–50. 9 indexed citations

20.

Falconi, Massimo, Aldo Scarpa, Patrick S. Moore, et al.. (2004). Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11. Journal of Cancer Research and Clinical Oncology. 130(6). 339–345. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact